Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study

INTRODUCTION: Although tamoxifen (TAM) plus ovarian function suppression (OFS) is considered as a standard adjuvant treatment for premenopausal women with hormone receptor-positive breast cancer, the optimal duration of OFS has not yet been established. This retrospective study was designed to asses...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer
Main Authors: Ozaki, Yukinori, Tanabe, Yuko, Tamura, Nobuko, Ogura, Takuya, Kondoh, Chihiro, Miura, Yuji, Yoshimura, Kenichi, Kawabata, Hidetaka, Takano, Toshimi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906507/
https://ncbi.nlm.nih.gov/pubmed/29357022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12282-018-0836-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados